EpiPen Pricing Flap Prompts New Drug Transparency Bill

EpiPen Pricing Flap Prompts New Drug Transparency Bill-rollcall: The controversy over the cost of EpiPens is prompting a bipartisan effort to force drugmakers to detail their costs before they increase prices by more than 10 percent.